Literature DB >> 20734706

Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme.

H Mkocha1, B Munoz, S West.   

Abstract

Trachoma, a blinding eye disease caused by repeated and prolonged infection with Chlamydia trachomatis, is a significant public health problem for sub-Saharan Africa. Tanzania has had a National Trachoma Task Force since 1999, working on trachoma control in endemic districts. The objective of this study was twofold: first, to determine the current status of infection and clinical trachoma in these districts in Tanzania, and second, to determine if a combination of clinical signs could be used as a surrogate for infection. We conducted a survey for trachoma and infection with C. trachomatis in 75 villages in eight districts of Kongwa, Kilosa, Mpwapwa, Bahi, Kondoa, Manyoni, Monduli and Iramba in Tanzania, which have previously been shown to be endemic. In each village, a random sample of households, and of children within households, was taken for examination. Trachoma was graded using the World Health Organization system, which we expanded, and a swab taken to determine presence of infection. The rates of trachoma ranged from 0% in Iramba District to 15.17% in Monduli District, with large variation in villages within districts. Infection rates were generally lower than trachoma rates, as expected, and most districts had villages with no infection. A combination of clinical signs of trachoma in children, when absent, showed very high specificity for identifying villages with no infection. We conclude that these signs might be useful for monitoring absence of infection in villages, and that districts with trachoma prevalence between 10% and 15% should have village level rapid surveys to avoid unnecessary mass treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20734706     DOI: 10.4314/thrb.v11i3.47694

Source DB:  PubMed          Journal:  Tanzan J Health Res        ISSN: 1821-9241


  12 in total

1.  Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection?

Authors:  Beatriz Munoz; Dianne Stare; Harran Mkocha; Charlotte Gaydos; Thomas Quinn; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-11       Impact factor: 4.799

2.  Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.

Authors:  Jeremy D Keenan; Berhan Ayele; Teshome Gebre; Jeanne Moncada; Nicole E Stoller; Zhaoxia Zhou; Travis C Porco; Charles E McCulloch; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Thomas M Lietman
Journal:  Clin Infect Dis       Date:  2011-11-17       Impact factor: 9.079

3.  Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.

Authors:  Sheila K West; Beatriz Munoz; Harran Mkocha; Charlotte A Gaydos; Thomas C Quinn
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

4.  A cross-sectional survey of water and clean faces in trachoma endemic communities in Tanzania.

Authors:  Morgan Rog; Bonnielin Swenor; Luis C Cajas-Monson; Wilson Mchiwe; Steven Kiboko; Harran Mkocha; Sheila West
Journal:  BMC Public Health       Date:  2011-06-24       Impact factor: 3.295

5.  Risk factors for ocular chlamydia after three mass azithromycin distributions.

Authors:  Berhan Ayele; Teshome Gebre; Jeanne Moncada; Jenafir I House; Nicole E Stoller; Zhaoxia Zhou; Travis C Porco; Bruce D Gaynor; Paul M Emerson; Julius Schachter; Jeremy D Keenan
Journal:  PLoS Negl Trop Dis       Date:  2011-12-13

6.  Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts.

Authors:  Jeremy D Keenan; Peter J Hotez; Abdou Amza; Nicole E Stoller; Bruce D Gaynor; Travis C Porco; Thomas M Lietman
Journal:  PLoS Negl Trop Dis       Date:  2013-12-05

7.  The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining.

Authors:  Salman A Rahman; Sheila K West; Harran Mkocha; Beatriz Munoz; Travis C Porco; Jeremy D Keenan; Thomas M Lietman
Journal:  PLoS Negl Trop Dis       Date:  2015-03-27

Review 8.  Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions.

Authors:  Diane K Lavett; Van C Lansingh; Marissa J Carter; Kristen A Eckert; Juan C Silva
Journal:  ScientificWorldJournal       Date:  2013-05-19

9.  Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.

Authors:  Sheila K West; Beatriz Munoz; Jerusha Weaver; Zakayo Mrango; Laura Dize; Charlotte Gaydos; Thomas C Quinn; Diana L Martin
Journal:  PLoS Negl Trop Dis       Date:  2016-01-15

10.  Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands.

Authors:  Robert M R Butcher; Oliver Sokana; Kelvin Jack; Colin K Macleod; Michael E Marks; Eric Kalae; Leslie Sui; Charles Russell; Helena J Tutill; Rachel J Williams; Judith Breuer; Rebecca Willis; Richard T Le Mesurier; David C W Mabey; Anthony W Solomon; Chrissy H Roberts
Journal:  PLoS Negl Trop Dis       Date:  2016-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.